The UK has recently approved a second vaccine that protects against HPV called Cervarix from GSK, in addition to Gardasil from Merck. Both vaccines protect against HPV, but Gardasil also protects against gentical warts, which Cervarix does not. Male with genital warts – image courtesy of Wikipedia The wholesale price for the two is exactly [...]
Entries from June 22nd, 2008
Cervical cancer vaccines
June 22nd, 2008 · No Comments · cancer, cervical cancer, company news, competitive intelligence, market intelligence, market trends, skin cancer
Tags:
Are Her2 inhibitors an alternative to chemo in breast cancer?
June 11th, 2008 · 1 Comment · breast cancer, cancer, competitive intelligence, market intelligence, market trends, oncology, pipeline
Image via WikipediaSeveral studies exploring the use of lapatinib (Tykerb, GlaxoSmithKline) in metastatic breast cancer have suggested that it may offer an alternative to chemotherapy in this setting, both as monotherapy, and in combination with other targeted therapies. One study explored the use of lapatinib alone, whereas others investigated combinations with trastuzumab (Herceptin, Genentech/Roche), with [...]
Tags:
Erbitux extends overall survival by 5 weeks in lung cancer
June 2nd, 2008 · No Comments · cancer, company news, competitive intelligence, lung cancer, market intelligence, market trends, oncology
ImClone announced that late-stage study data showed that first-line treatment with Erbitux (cetuximab) plus standard chemotherapy significantly increased overall survival by about five weeks in patients with advanced non-small cell lung cancer (NSCLC), compared with chemotherapy alone. The results were presented at the American Society of Clinical Oncology (ASCO) meeting this weekend. To put things [...]
Tags: